FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention describes 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene of the formula (I) as crystalline modifications A, B and C. Each modification shows a diffraction roentgenogram with reflexes no coinciding with reflexes of two other modifications. Crystalline modifications A, B, C are designated for preparing pharmaceutical compositions with anticonvulsive, antipyretic and analgetic effect. Invention describes also methods of preparing the indicated modifications. EFFECT: improved method of preparing, valuable medicinal properties of compositions. 13 cl, 5 dwg
Authors
Dates
2002-08-10—Published
1998-01-09—Filed